You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HS

Showing 1 - 25 of 7,568
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Beijing (HS-20094 5mg, HS-20094 10mg, HS-20094 15mg)

Recruiting
  • Type 2 Diabetes
  • HS-20094 5mg
  • +3 more
  • Beijing, Beijing, China
    Peking University First Hospital
Nov 3, 2023

Cough Trial in Jinan (HS-10383, HS-10383 Placebo)

Recruiting
  • Cough
  • Jinan, Shandong, China
    Shandong provincial qianfoshan hospital
Oct 19, 2023

Hidradenitis Suppurativa Trial in Worldwide (Bimekizumab, Placebo)

Active, not recruiting
  • Hidradenitis Suppurativa
  • Birmingham, Alabama
  • +87 more
Feb 2, 2023

Psoriasis Trial in Shanghai (HS-10374 tablets 1mg, HS-10374 tablets 5mg, HS-10374-matched tablets)

Not yet recruiting
  • Psoriasis
  • HS-10374 tablets 1mg
  • +2 more
  • Shanghai, Shanghai, China
    Huashan Hospital of Fudan University
Oct 8, 2023

Endometriosis Trial (HS-10518, Placebo)

Not yet recruiting
  • Endometriosis
  • (no location specified)
Nov 1, 2023

MDD (MDD) Trial (HS-10353 30mg oral capsules, HS-10353 50mg oral capsules, Placebo for HS-10353 30mg capsules)

Not yet recruiting
  • Major Depressive Disorder (MDD)
  • HS-10353 30mg oral capsules
  • +3 more
  • (no location specified)
Jul 10, 2023

Vasomotor Symptoms Trial in Peking (HS-10384 tablets, HS-10384-matched tablets)

Not yet recruiting
  • Vasomotor Symptoms
  • HS-10384 tablets
  • HS-10384-matched placebo tablets
  • Peking, Beijing, China
    Peking University Third Hospital
Nov 7, 2023

Advanced Solid Tumor Trial (HS-20105)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Nov 17, 2023

Postpartum Depression Trial (HS-10353 Capsules 30 mg, Oral, QN for 14 days, HS-10353 Capsules 50 mg, Oral, QN for 14 days,

Not yet recruiting
  • Postpartum Depression
  • HS-10353 Capsules 30 mg, Oral, QN for 14 days
  • +3 more
  • (no location specified)
Jul 2, 2023

Hidradenitis Suppurativa Trial in Worldwide (Bimekizumab, Placebo)

Completed
  • Hidradenitis Suppurativa
  • Fountain Valley, California
  • +90 more
Nov 8, 2022

Overweight and Obesity Trial in Harbin (HS-20094, Placebo)

Recruiting
  • Overweight and Obesity
  • Harbin, Heilongjiang, China
  • +1 more
Nov 3, 2023

Healthy Trial (HS-10506, HS-10506 Placebo)

Not yet recruiting
  • Healthy
  • (no location specified)
Jul 12, 2023

Psoriasis Trial in Shanghai (HS-10374 tablets, HS-10374-matched tablets)

Completed
  • Psoriasis
  • HS-10374 tablets
  • HS-10374-matched placebo tablets
  • Shanghai, Shanghai, China
    Huashan Hospital Affiliated to Fudan University
Sep 5, 2023

Renal Cell Carcinoma Trial (HS-10516)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Sep 24, 2023

COVID-19 Trial in Jinan (HS-10517 Dose 1, HS-10517 Dose 2, HS-10517 Dose 3)

Recruiting
  • COVID-19
  • HS-10517 Dose 1
  • +4 more
  • Jinan, Shandong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Mar 9, 2023

Advanced Solid Tumor Trial (HS-20093)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Oct 29, 2023

Schizophrenia Trial (HS-10380, Placebo)

Not yet recruiting
  • Schizophrenia
  • (no location specified)
Jul 19, 2023

Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer (ES-SCLC)
  • (no location specified)
Sep 19, 2023

Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)

Not yet recruiting
  • Metastasis Castration Resistant Prostate Cancer(mCRPC)
  • (no location specified)
Aug 14, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Beijing, Beijing, China
    Lingying Wu
Aug 22, 2023

Osteosarcoma, Sarcoma Trial (HS-20093)

Not yet recruiting
  • Osteosarcoma
  • Sarcoma
  • (no location specified)
Apr 26, 2023

Advanced Solid Tumor Trial in Shanghai (HS-10386)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Jun 20, 2023

Head and Neck Squamous Cell Carcinoma Trial (HS-20093)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Aug 17, 2023

NSCLC, Solid Tumor Trial in Tianjin (HS-20117)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Solid Tumor
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jul 10, 2023

Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

Recruiting
  • Nonsmall Cell Lung Cancer
  • HS-10365 capsules
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 22, 2023